Details for New Drug Application (NDA): 210233
✉ Email this page to a colleague
NDA 210233 describes ESTRADIOL AND NORETHINDRONE ACETATE, which is a drug marketed by Barr, Breckenridge Pharm, Naari Pte Ltd, Novast Labs, Teva Pharms Usa, and Xiromed, and is included in six NDAs. It is available from five suppliers. Additional details are available on the ESTRADIOL AND NORETHINDRONE ACETATE profile page.
The generic ingredient in ESTRADIOL AND NORETHINDRONE ACETATE is estradiol; norethindrone acetate. There are seventy-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the estradiol; norethindrone acetate profile page.
The generic ingredient in ESTRADIOL AND NORETHINDRONE ACETATE is estradiol; norethindrone acetate. There are seventy-five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the estradiol; norethindrone acetate profile page.
Summary for 210233
| Tradename: | ESTRADIOL AND NORETHINDRONE ACETATE |
| Applicant: | Naari Pte Ltd |
| Ingredient: | estradiol; norethindrone acetate |
| Patents: | 0 |
Pharmacology for NDA: 210233
| Mechanism of Action | Estrogen Receptor Agonists |
Suppliers and Packaging for NDA: 210233
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ESTRADIOL AND NORETHINDRONE ACETATE | estradiol; norethindrone acetate | TABLET;ORAL | 210233 | ANDA | Naari Pte. Limited | 79929-012 | 79929-012-07 | 84 BLISTER PACK in 1 POUCH (79929-012-07) / 28 TABLET in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG;0.5MG | ||||
| Approval Date: | Feb 28, 2018 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
